Literature DB >> 25527651

Analysis of Green Light Committee implementation and acquisition of second-line drug resistance.

John Z Metcalfe1, Eric Vittinghoff2, Philip C Hopewell1.   

Abstract

Mesh：

Substances：

Year:  2014        PMID： 25527651      PMCID： PMC6276940          DOI： 10.1093/cid/ciu1147

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  10 in total

Review 1.  From multidrug-resistant tuberculosis to DOTS expansion and beyond: making the most of a paradigm shift.

Authors:  Jim Yong Kim; Joia S Mukherjee; Michael L Rich; Kedar Mate; Jaime Bayona; Mercedes C Becerra
Journal:  Tuberculosis (Edinb)       Date:  2003       Impact factor: 3.131

2.  Scaling-up treatment for HIV/AIDS: lessons learned from multidrug-resistant tuberculosis.

Authors:  Rajesh Gupta; Alexander Irwin; Mario C Raviglione; Jim Yong Kim
Journal:  Lancet       Date:  2004-01-24       Impact factor: 79.321

3.  Propensity-matching analysis is not straightforward.

Authors:  Sylvie Chevret
Journal:  Am J Respir Crit Care Med       Date:  2014-08-15       Impact factor: 21.405

4.  Time to sputum culture conversion in multidrug-resistant tuberculosis: predictors and relationship to treatment outcome.

Authors:  Timothy H Holtz; Maya Sternberg; Steve Kammerer; Kayla F Laserson; Vija Riekstina; Evija Zarovska; Vija Skripconoka; Charles D Wells; Vaira Leimane
Journal:  Ann Intern Med       Date:  2006-05-02       Impact factor: 25.391

5.  Delamanid for multidrug-resistant pulmonary tuberculosis.

Authors:  Maria Tarcela Gler; Vija Skripconoka; Epifanio Sanchez-Garavito; Heping Xiao; Jose L Cabrera-Rivero; Dante E Vargas-Vasquez; Mengqiu Gao; Mohamed Awad; Seung-Kyu Park; Tae Sun Shim; Gee Young Suh; Manfred Danilovits; Hideo Ogata; Anu Kurve; Joon Chang; Katsuhiro Suzuki; Thelma Tupasi; Won-Jung Koh; Barbara Seaworth; Lawrence J Geiter; Charles D Wells
Journal:  N Engl J Med       Date:  2012-06-07       Impact factor: 91.245

6.  Extensive drug resistance acquired during treatment of multidrug-resistant tuberculosis.

Authors:  J Peter Cegielski; Tracy Dalton; Martin Yagui; Wanpen Wattanaamornkiet; Grigory V Volchenkov; Laura E Via; Martie Van Der Walt; Thelma Tupasi; Sarah E Smith; Ronel Odendaal; Vaira Leimane; Charlotte Kvasnovsky; Tatiana Kuznetsova; Ekaterina Kurbatova; Tiina Kummik; Liga Kuksa; Kai Kliiman; Elena V Kiryanova; HeeJin Kim; Chang-ki Kim; Boris Y Kazennyy; Ruwen Jou; Wei-Lun Huang; Julia Ershova; Vladislav V Erokhin; Lois Diem; Carmen Contreras; Sang Nae Cho; Larisa N Chernousova; Michael P Chen; Janice Campos Caoili; Jaime Bayona; Somsak Akksilp
Journal:  Clin Infect Dis       Date:  2014-07-23       Impact factor: 9.079

7.  Constructing inverse probability weights for marginal structural models.

Authors:  Stephen R Cole; Miguel A Hernán
Journal:  Am J Epidemiol       Date:  2008-08-05       Impact factor: 4.897

8.  Successful '9-month Bangladesh regimen' for multidrug-resistant tuberculosis among over 500 consecutive patients.

Authors:  K J M Aung; A Van Deun; E Declercq; M R Sarker; P K Das; M A Hossain; H L Rieder
Journal:  Int J Tuberc Lung Dis       Date:  2014-10       Impact factor: 2.373

9.  Comparison of levofloxacin versus moxifloxacin for multidrug-resistant tuberculosis.

Authors:  Won-Jung Koh; Seung Heon Lee; Young Ae Kang; Chang-Hoon Lee; Jae Chol Choi; Jae Ho Lee; Seung Hun Jang; Kwang Ha Yoo; Ki Hwan Jung; Ki Uk Kim; Sang Bong Choi; Yon Ju Ryu; Kyung Chan Kim; Soojung Um; Yong Soo Kwon; Yee Hyung Kim; Won-Il Choi; Kyeongman Jeon; Yong Il Hwang; Se Joong Kim; Young Seok Lee; Eun Young Heo; Juhee Lee; Yeo Woon Ki; Tae Sun Shim; Jae-Joon Yim
Journal:  Am J Respir Crit Care Med       Date:  2013-10-01       Impact factor: 21.405

10.  Outcome of standardized treatment for patients with MDR-TB from Tamil Nadu, India.

Authors:  Pauline Joseph; Vijaya Bhaskara Rao Desai; Nalini Sunder Mohan; Jemima Sheila Fredrick; Rajeswari Ramachandran; Balambal Raman; Fraser Wares; Ranjani Ramachandran; Aleyamma Thomas
Journal:  Indian J Med Res       Date:  2011-05       Impact factor: 2.375
  10 in total
  1 in total

1.  Reply to Soman et al, Alffenaar et al, Metcalfe et al, and Raoult.

Authors:  J Peter Cegielski; Michael P Chen; Thelma E Tupasi; Vaira Leimane; Grigory V Volchenkov
Journal:  Clin Infect Dis       Date:  2014-12-19       Impact factor: 9.079
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.